In the article on the cytoplasmic retention of RUNX3 in the September 1, 2005 issue of Cancer Research (1), in the last paragraph of the Materials and Methods section on page 7744, the second to last sentence should have read the following: “Human TGF-β1 (2 ng/mL; R&D Systems, Minneapolis, MN) was added to the culture medium 48 hours after the transfection.” Also, the title of Table 1 on page 7747 should have read as follows: “Table 1. Subcellular localization of RUNX3 in gastric cancer tissues.”

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Cancer Res